SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-01-506357
Filing Date
2001-04-02
Accepted
2001-04-02 00:00:00
Documents
11
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2042542z10-k.txt 10-K 199607
2 EXHIBIT 3.4 a2042542zex-3_4.txt EX-3.4 25616
3 EXHIBIT 3.7 a2042542zex-3_7.txt EX-3.7 2322
4 EXHIBIT 10.27 a2042542zex-10_27.txt EX-10.27 61318
5 EXHIBIT 10.28 a2042542zex-10_28.txt EX-10.28 4915
6 EXHIBIT 10.29 a2042542zex-10_29.txt EX-10.29 149887
7 EXHIBIT 10.30 a2042542zex-10_30.txt EX-10.30 9094
8 EXHIBIT 10.31 a2042542zex-10_31.txt EX-10.31 23916
9 EXHIBIT 10.32 a2042542zex-10_32.txt EX-10.32 41300
10 EXHIBIT 21.1 a2042542zex-21_1.txt EX-21.1 258
11 EXHIBIT 23.1 a2042542zex-23_1.txt EX-23.1 829
  Complete submission text file 0000912057-01-506357.txt   521622
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21481 | Film No.: 1590742
SIC: 2836 Biological Products, (No Diagnostic Substances)